From The Hindu BusinessLine
Center-Right Owned by The Hindu Group (Kasturi & Sons)Fredun Pharmaceuticals Q2 results: Net profit jumps 90% on better demand
What's behind this
Divi's Laboratories reported a strong second‑quarter performance, with net profit increasing 64% to Rs 1,127 crore and revenue rising 35% year‑on‑year. EBITDA grew 76% to Rs 1,566 crore, up from Rs 888 crore in the same period last year, reflecting an expansion in margins.
AI-generated overview from 2 outlets. It summarises their reporting and adds no reporting of its own.
What each side is saying
One outlet's own words from each side of the spectrum. Quoted, not summarised.
-
left · 1 outlet
Along with the results, the company declared an interim dividend of ₹8 per equity share.
-
center · 1 outlet
Mamaearth parent Honasa Consumer reported an 86.7% increase in its consolidated net profit to ₹73.2 Cr in the September quarter…
— Inc42
-
right · 2 outlets
Tata Steel posts a stronger-than-expected Q2 performance, with revenue and EBITDA beating estimates. The company expects H2 to be stronger across India and the Netherlands.
— NDTV
RSS excerpt
Fredun Pharmaceuticals’ Q2 FY27 revenue climbs 85% to ₹266 crore
